Kopran Ltd.
Description Kopran Limited and its subsidiaries engage in the manufacture, import, export, and sale of pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients (APIs) and finished dosage forms. The companys APIs primarily include cefixime trihydrate, cefditoren pivoxil, cefotaxime sodium, ceftriaxone sodium, cefepime + L arginine, atenolol, amlodipine besilate, azithromycin dihydrate, roxithromycin, clarithromycin, clarithromycin granules, and pregabalin. Its API products under development comprise metoprolol succinates, metoprolol tartrates, and etodolacs. The companys finished dosage forms include antibiotics, cardiovasculars, anti-diabetes, respiratory/anti-asthmatics, gastrointestinals, pain management, anti-malarials, anthelmentics, antiprotozoals, anti-allergics, anti-retorvirals, CNS, drugs for erectile dysfunction, and other forms of drugs. These products are offered in various dosage forms, including tablets, capsules, liquids, and injectables. The company is based in Mumbai, India. To view the detailed information, you need to SUBSCRIBE with us. |
 |